| Patent | Date |
|---|
Prophylactic and/or therapeutic agent containing pyridylaminoacetic acid compound
Grant 11,331,311 - Kirihara , et al. May 17, 2 | 2022-05-17 |
Prophylactic And/or Therapeutic Agent Containing Pyridylaminoacetic Acid Compound
App 20200206200 - KIRIHARA; Tomoko ; et al. | 2020-07-02 |
Prophylactic And/or Therapeutic Agent Containing Pyridylaminoacetic Acid Compound
App 20180200239 - KIRIHARA; Tomoko ; et al. | 2018-07-19 |
Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension
Grant 10,016,441 - Ellis , et al. July 10, 2 | 2018-07-10 |
Prostaglandin Conjugates And Derivatives For Treating Glaucoma And Ocular Hypertension
App 20170239268 - Ellis; David Archer ; et al. | 2017-08-24 |
Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypertension
Grant 9,604,949 - Ellis , et al. March 28, 2 | 2017-03-28 |
Prostaglandin Conjugates And Derivatives For Treating Glaucoma And Ocular Hypertension
App 20160108012 - Ellis; David ; et al. | 2016-04-21 |
Bradykinin Receptor Agonists And Uses Thereof To Treat Ocular Hypertension And Glaucoma
App 20120283260 - Combrink; Keith D. ; et al. | 2012-11-08 |
Use of bradykinin and related B2R agonists to treat ocular hypertension and glaucoma
Grant 8,263,555 - Sharif September 11, 2 | 2012-09-11 |
Bradykinin receptor agonists and uses thereof to treat ocular hypertension and glaucoma
Grant 8,252,793 - Combrink , et al. August 28, 2 | 2012-08-28 |
Use of non-peptidic bradykinin receptor agonists to treat ocular hypertension and glaucoma
Grant 8,173,668 - Sharif May 8, 2 | 2012-05-08 |
Bradykinin Receptor Agonists And Uses Thereof To Treat Ocular Hypertension And Glaucoma
App 20120046285 - Combrink; Keith D. ; et al. | 2012-02-23 |
Use Of Multi-pharmacophore Compounds To Treat Nasal Disorders
App 20110195962 - Sharif; Najam A. ; et al. | 2011-08-11 |
Use Of Bradykinin And Related B2r Agonists To Treat Ocular Hypertension And Glaucoma
App 20110009322 - SHARIF; Najam A. | 2011-01-13 |
Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-mediated diseases and conditions
Grant 7,867,999 - Chen , et al. January 11, 2 | 2011-01-11 |
Use of bradykinin and related B.sub.2R agonists to treat ocular hypertension and glaucoma
Grant 7,807,629 - Sharif October 5, 2 | 2010-10-05 |
Antagonists Of Ci-m6p/igf2r For Prevention And Treatment Of Ctgf-mediated Ocular Disorders
App 20100247548 - Shepard; Allan R. ; et al. | 2010-09-30 |
USE OF AGENTS THAT DOWN-REGULATE EXPRESSION OF TANIS AND/OR P21 Waf1/Cip1/Sd1 GENES, AND USE OF AGENTS THAT INHIBIT, DEGRADE, SEQUESTER OR PREVENT THE NEUROTOXICITY OF GENE PRODUCT PROTEINS OF TANIS AND P21 Waf1/Cip1/Sd1 GENES
App 20100173852 - Drace; Colene D. ; et al. | 2010-07-08 |
Method for treating glaucoma comprising administering .alpha.-lipoic acid
Grant 7,718,697 - Drace , et al. May 18, 2 | 2010-05-18 |
(Indazol-5-yl)-pyrazines and (1,3-dihydro-indol-2-one)-pyrazines for treating glaucoma and controlling intraocular pressure
Grant 7,655,662 - Hellberg , et al. February 2, 2 | 2010-02-02 |
Use Of Agents That Prevent The Generation Of Amyloid-like Proteins And/or Drusen, And/or Use Of Agents That Promote Sequestration And/or Degradation Of, And/or Prevent The Neurotoxic Effects Of Such Proteins In The Treatment Of Macular Degeneration
App 20090203614 - Sharif; Najam A. | 2009-08-13 |
Use Of Agents That Prevent Generation Of Amyloid And Amyloid-like Lipoproteins, And/or Use Of Agents That Promote Sequestration And/or Degradation Of, And/or Prevent Neurotoxicity Of Such Proteins In The Treatment Of Hearing Loss And Improving Body Balance
App 20090181893 - Sharif; Najam A. | 2009-07-16 |
Use of Natriuretic Peptide Receptor Antagonists to Treat Ocular, Otic and Nasal Edemetous Conditions
App 20090181896 - Sharif; Najam A. ; et al. | 2009-07-16 |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF OCULAR NEOVASCULARIZATION
App 20090054365 - Patil; Rajkumar V. ; et al. | 2009-02-26 |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF IOP-RELATED CONDITIONS
App 20080214486 - Chatterton; Jon E. ; et al. | 2008-09-04 |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 4 FOR TREATMENT OF OCULAR NEOVASCULARIZATION
App 20080194513 - Patil; Rajkumar V. ; et al. | 2008-08-14 |
RNAi-MEDIATED INHIBITION OF AQUAPORIN 1 FOR TREATMENT OF IOP-RELATED CONDITIONS
App 20080171719 - Chatterton; Jon E. ; et al. | 2008-07-17 |
High Throughput Assay For Human Rho Kinase Activity With Enhanced Signal-to-noise Ratio
App 20080096238 - Sharif; Najam A. ; et al. | 2008-04-24 |
Antagonists Of Ci-m6p/igf2r For Prevention And Treatment Of Ctgf-mediated Ocular Disorders
App 20080057072 - SHEPARD; Allan R. ; et al. | 2008-03-06 |
Serotonergic 5HT.sub.7 receptor compounds for treating ocular and CNS disorders
Grant 7,285,553 - May , et al. October 23, 2 | 2007-10-23 |
Use Of Natriuretic Peptide Receptor Antagonists To Treat Ocular, Otic And Nasal Edemetous Conditions
App 20070225225 - Sharif; Najam A. ; et al. | 2007-09-27 |
(indazol-5-yl)-pyrazines And (1,3-dihydro-indol-2-one)-pyrazines For Treating Rho Kinase-mediated Diseases And Conditions
App 20070149548 - Hellberg; Mark R. ; et al. | 2007-06-28 |
Methods of treating dry eye disorders
Grant 7,235,556 - Sharif , et al. June 26, 2 | 2007-06-26 |
Serotonergic 5HT.sub.7 receptor compounds for treating ocular and CNS disorders
Grant 7,060,704 - May , et al. June 13, 2 | 2006-06-13 |
Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration
App 20060121039 - Sharif; Najam A. | 2006-06-08 |
High throughput assay for human Rho kinase activity
App 20060115870 - Sharif; Najam A. ; et al. | 2006-06-01 |
Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
App 20060052372 - May; Jesse A. ; et al. | 2006-03-09 |
Serotonergic 5HT.sub.7 receptor compounds for treating ocular and CNS disorders
Grant 6,960,579 - May , et al. November 1, 2 | 2005-11-01 |
Use of Rho kinase inhibitors in the treatment of hearing loss, tinnitus and improving body balance
App 20050222127 - Sharif, Najam A. | 2005-10-06 |
Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders
App 20050187214 - May, Jesse A. ; et al. | 2005-08-25 |
Use of agents that prevent generation of amyloid and amyloid-like lipoproteins, and/or use of agents that promote sequestration and/or degradation of, and/or prevent neurotoxicity of such proteins in the treatment of hearing loss and improving body balance
App 20050137122 - Sharif, Najam A. | 2005-06-23 |
Use of agents that down-regulate expression of tanis and/or p21^Waf1/Cip1/Sd1 genes, and use of agents that inhibit, degrade, sequester or prevent the neurotoxicity of gene product proteins of tanis and p21^Waf1/Cip1/Sd1 genes
App 20050137123 - Drace, Colene D. ; et al. | 2005-06-23 |
Methods of treating dry eye disorders
App 20040209888 - Sharif, Najam A. ; et al. | 2004-10-21 |
Serotonergic 5ht2 agonists for treating glaucoma
Grant 6,664,286 - May , et al. December 16, 2 | 2003-12-16 |
11.beta.-fluoro 15.beta.-hydroxy PGF2.alpha. analogs as FP receptor antagonists
Grant 6,649,655 - Sharif , et al. November 18, 2 | 2003-11-18 |
Serotonergic 5HT2 agonists for treating glaucoma
App 20030203912 - May, Jesse A. ; et al. | 2003-10-30 |
11Beta-fluoro 15beta-hydroxy PGF2alpha analogs as FP receptor antagonists
App 20030083375 - Sharif, Najam A. ; et al. | 2003-05-01 |
Non-peptide bradykinin receptor antagonists for use in controlling intraocular pressure and treating glaucoma
Grant 6,500,831 - Sharif December 31, 2 | 2002-12-31 |
11-deoxy-16-fluoro-PGF2.alpha. analogs as FP receptor antagonists
Grant 6,492,417 - Sharif , et al. December 10, 2 | 2002-12-10 |
Prostaglandin e agonists for treatment of dry eye
Grant 6,344,477 - Sharif February 5, 2 | 2002-02-05 |
Immortalized human corneal epithelial cell line
Grant 6,284,537 - Offord Cavin , et al. September 4, 2 | 2001-09-04 |
| 